Neoadjuvant treatment with toripalimab and axitinib has demonstrated efficacy in a phase 2 trial of patients with resectable mucosal melanoma, according to researchers.
Clinical Trials
Perspective Therapeutics enrols patients in melanoma drug trial
Medical technology and radiopharmaceutical company Perspective Therapeutics has enrolled the first patient cohort in its Phase I/IIa dose escalation study of ²¹²Pb-VMT01 to treat MC1R-positive metastatic melanoma.
Neoadjuvant Daromun Meets Primary End Point of RFS in Melanoma
A trial of intratumoral daromun and surgical resection for the treatment of patients with locally advanced, fully resectable melanoma, showed a clinically meaningful improvement compared with surgery alone.
Lifileucel Demonstrates Efficacy in Advanced Mucosal Melanoma Following Progression on Immune Checkpoint Inhibitors
Lifileucel demonstrated clinically meaningful activity in patients with advanced mucosal melanoma who experienced disease progression on immune checkpoint inhibitors, according to findings from a subgroup of patients in the phase 2 C-144-01 study.